financetom
Business
financetom
/
Business
/
Thermo Fisher Scientific Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Thermo Fisher Scientific Unusual Options Activity
Feb 21, 2025 12:38 PM

Investors with a lot of money to spend have taken a bullish stance on Thermo Fisher Scientific ( TMO ) .

And retail traders should know.

We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with TMO, it often means somebody knows something is about to happen.

Today, Benzinga's options scanner spotted 8 options trades for Thermo Fisher Scientific ( TMO ).

This isn't normal.

The overall sentiment of these big-money traders is split between 25% bullish and 12%, bearish.

Out of all of the options we uncovered, 7 are puts, for a total amount of $317,353, and there was 1 call, for a total amount of $35,057.

Expected Price Movements

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $500.0 to $610.0 for Thermo Fisher Scientific ( TMO ) over the last 3 months.

Volume & Open Interest Trends

In terms of liquidity and interest, the mean open interest for Thermo Fisher Scientific ( TMO ) options trades today is 223.5 with a total volume of 322.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Thermo Fisher Scientific's ( TMO ) big money trades within a strike price range of $500.0 to $610.0 over the last 30 days.

Thermo Fisher Scientific Option Activity Analysis: Last 30 Days

Largest Options Trades Observed:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
TMO PUT TRADE BEARISH 02/21/25 $24.5 $22.8 $24.5 $560.00 $66.1K 504 17
TMO PUT TRADE NEUTRAL 02/21/25 $25.8 $23.1 $24.6 $560.00 $51.6K 504 83
TMO PUT TRADE BULLISH 03/20/26 $43.3 $38.9 $40.61 $530.00 $44.6K 2 11
TMO PUT TRADE NEUTRAL 02/21/25 $25.8 $23.1 $24.6 $560.00 $44.2K 504 101
TMO PUT SWEEP BULLISH 06/20/25 $13.1 $12.3 $12.3 $500.00 $40.5K 388 37

About Thermo Fisher Scientific

Thermo Fisher Scientific ( TMO ) sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).

Present Market Standing of Thermo Fisher Scientific

With a trading volume of 788,069, the price of TMO is down by -0.81%, reaching $533.5.

Current RSI values indicate that the stock is may be approaching oversold.

Next earnings report is scheduled for 61 days from now.

Professional Analyst Ratings for Thermo Fisher Scientific

5 market experts have recently issued ratings for this stock, with a consensus target price of $672.4.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.

* An analyst from UBS has decided to maintain their Buy rating on Thermo Fisher Scientific ( TMO ), which currently sits at a price target of $715.

* Maintaining their stance, an analyst from Scotiabank continues to hold a Sector Perform rating for Thermo Fisher Scientific ( TMO ), targeting a price of $650.

* An analyst from Raymond James downgraded its action to Outperform with a price target of $667.

* Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Thermo Fisher Scientific ( TMO ) with a target price of $680.

* An analyst from Citigroup has decided to maintain their Neutral rating on Thermo Fisher Scientific ( TMO ), which currently sits at a price target of $650.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Thermo Fisher Scientific ( TMO ) options trades with real-time alerts from Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Couchbase Insider Sold Shares Worth $1,542,319, According to a Recent SEC Filing
Couchbase Insider Sold Shares Worth $1,542,319, According to a Recent SEC Filing
Jun 24, 2025
05:02 PM EDT, 06/24/2025 (MT Newswires) -- Matthew M Cain, Director, Chair, President, and CEO, on June 20, 2025, sold 63,600 shares in Couchbase ( BASE ) for $1,542,319. Following the Form 4 filing with the SEC, Cain has control over a total of 888,747 common shares of the company, with 888,747 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1845022/000164234625000007/xslF345X05/wk-form4_1750798646.xml ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Jack in the Box Appoints Shannon McKinney as COO
Jack in the Box Appoints Shannon McKinney as COO
Jun 24, 2025
05:03 PM EDT, 06/24/2025 (MT Newswires) -- Jack in the Box (JACK) said Tuesday it has appointed Shannon McKinney as its chief operating officer. McKinney served as Jack in the Box's vice president of operations and brand performance from March 2019 to August 2021. McKinney most recently worked as regional vice president of operations and vice president of operations, PLK,...
Cue Biopharma Receives FDA Feedback for Trial Design of Drug Candidate to Treat Autoimmune Diseases
Cue Biopharma Receives FDA Feedback for Trial Design of Drug Candidate to Treat Autoimmune Diseases
Jun 24, 2025
05:01 PM EDT, 06/24/2025 (MT Newswires) -- Cue Biopharma ( CUE ) said late Tuesday it received pre-investigational new drug feedback from the US Food and Drug Administration on its trial design for the CUE-401 drug candidate to treat T-cell mediated autoimmune and inflammatory diseases. As a result, the company said it plans to file an IND pending completion of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved